Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000448081

Medchemexpress LLC ARS-1630 | 1698055-86-5 | 430.84 | 25 MG
SDP

Catalog No. 5000448081
Encompass_Preferred

ARS-1630 is a novel inhibitor of mutant K-ras G12C, derived from patent WO 2015054572 A1. It is characterized as a less active enantiomer of ARS-1620. This compound targets mutant K-ras G12C, which is considered potentially druggable through allele-specific covalent targeting of Cys-12 near an inducible allosteric switch II pocket. This approach relies on the active cycling of KRAS G12C between its active-GTP and inactive-GDP conformations, as the accessibility of the switch II pocket is limited to the GDP-bound state.

  • Specifically inhibits mutant K-ras G12C.
  • It is a less active enantiomer of ARS-1620.
  • Molecular weight: 430.84.
  • Chemical formula: C21H17ClF2N4O2.
  • Appears as a white to yellow solid.

Catalog No. 50-004-48081 Supplier Medchemexpress LLC Supplier No. 25MGHYU00417
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ARS-1630 is a novel inhibitor of mutant K-ras G12C, derived from patent WO 2015054572 A1. It is characterized as a less active enantiomer of ARS-1620. This compound targets mutant K-ras G12C, which is considered potentially druggable through allele-specific covalent targeting of Cys-12 near an inducible allosteric switch II pocket. This approach relies on the active cycling of KRAS G12C between its active-GTP and inactive-GDP conformations, as the accessibility of the switch II pocket is limited to the GDP-bound state.

  • Specifically inhibits mutant K-ras G12C.
  • It is a less active enantiomer of ARS-1620.
  • Molecular weight: 430.84.
  • Chemical formula: C21H17ClF2N4O2.
  • Appears as a white to yellow solid.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.